Evidence map›Paper›PMID 38495483›Full record

ArticleJournal of Cancer2024

CHRNA9 as a New Prognostic Marker and Potential Therapeutic Target in Glioma.

Xiaoshan Ma, Ren Geng, Yao Zhao, Wanzhen Xu, Yao Li, Yining Jiang, Yuanhao Liu, Liyan Zhao, Yunqian Li

Abstract read
In one paragraph

Article in Journal of Cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xiaoshan MaDepartment of Neurosurgery, First Hospital of Jilin University, Changchun, China.
Ren GengDepartment of Neurosurgery, First Hospital of Jilin University, Changchun, China.
Yao ZhaoDepartment of Neurosurgery, First Hospital of Jilin University, Changchun, China.
Wanzhen XuDepartment of Neurosurgery, Qilu Hospital of Shandong University Dezhou Hospital, Dezhou, China.
Yao LiDepartment of Blood Transfusion, Second Hospital of Jilin University, Changchun, China.
Yining JiangDepartment of Neurosurgery, First Hospital of Jilin University, Changchun, China.
Yuanhao LiuDepartment of Neurosurgery, First Hospital of Jilin University, Changchun, China.
Liyan ZhaoDepartment of Blood Transfusion, Second Hospital of Jilin University, Changchun, China.
Yunqian LiDepartment of Neurosurgery, First Hospital of Jilin University, Changchun, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CHRNA9GliomaPrognostic MarkerSTAT3 PathwayTherapeutic Target

Identifiers

PMID38495483
PMCPMC10937273

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.